Co-Authors
This is a "connection" page, showing publications co-authored by Pierre Giglio and William Vandergrift.
Connection Strength
0.531
-
Synergistic Effects of Crizotinib and Temozolomide in Experimental FIG-ROS1 Fusion-Positive Glioblastoma. Cancer Growth Metastasis. 2015; 8:51-60.
Score: 0.140
-
Metastatic hepatocellular carcinoma with associated spinal cord compression. Am J Med Sci. 2011 Feb; 341(2):148-52.
Score: 0.100
-
Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastoma. Cancer Chemother Pharmacol. 2018 12; 82(6):945-952.
Score: 0.042
-
RIP1 and RIP3 complex regulates radiation-induced programmed necrosis in glioblastoma. Tumour Biol. 2016 Jun; 37(6):7525-34.
Score: 0.035
-
A novel component from citrus, ginger, and mushroom family exhibits antitumor activity on human meningioma cells through suppressing the Wnt/?-catenin signaling pathway. Tumour Biol. 2015 Sep; 36(9):7027-34.
Score: 0.033
-
Mechanisms and clinical significance of histone deacetylase inhibitors: epigenetic glioblastoma therapy. Anticancer Res. 2015 Feb; 35(2):615-25.
Score: 0.033
-
Current Studies of Immunotherapy on Glioblastoma. J Neurol Neurosurg. 2014 Apr 05; 1(1).
Score: 0.031
-
Molecular Targets and Treatment of Meningioma. J Neurol Neurosurg. 2014; 1(1).
Score: 0.031
-
Multi-targeted DATS prevents tumor progression and promotes apoptosis in ectopic glioblastoma xenografts in SCID mice via HDAC inhibition. J Neurooncol. 2013 Aug; 114(1):43-50.
Score: 0.029
-
Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma. Metab Brain Dis. 2013 Sep; 28(3):355-66.
Score: 0.029
-
Drug resistance in glioblastoma: a mini review. Neurochem Res. 2012 Jun; 37(6):1192-200.
Score: 0.027